Obesity Clinical Trials

Find Obesity Clinical Trials Near You

Gestational Response, Outcomes, and Weight After GLP-1 Use

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

The goal of this observational study is to learn if using GLP-1RA medications for weight loss before pregnancy influences gestational weight gain and pregnancy outcomes. The main aims of the study are to: * Compare gestational weight gain between women with preconception GLP-1RA exposure and those without exposure. * Compare obstetrical outcomes between women with preconception GLP-1RA exposure and those without exposure. Researchers will compare pregnant women with a history of GLP-1RA use to pregnant women who have not used a GLP-1RA to compare differences. Participants will be asked to complete questionnaires at multiple timepoints during and after pregnancy that ask questions about medication history, thoughts and feelings around food, etc.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 45
Healthy Volunteers: t
View:

• Adult women

• Less than or equal to 20 weeks gestation at first visit

• English speaking

Locations
United States
Kansas
University of Kansas Medical Center
RECRUITING
Kansas City
Contact Information
Primary
Molly Fain
mfain3@kumc.edu
913-588-5478
Time Frame
Start Date: 2026-04-13
Estimated Completion Date: 2028-04
Participants
Target number of participants: 400
Treatments
GLP-1RA users
Participants with a history of GLP-1RA use.
GLP-1RA nonusers
Participants who have never used a GLP-1RA medication.
Related Therapeutic Areas
Sponsors
Leads: University of Kansas Medical Center

This content was sourced from clinicaltrials.gov